ESC 365 - Lower dose direct oral anticoagulation and warfarin in atrial fibrillation. Ischemic stroke, intracranial hemorrhage and mortality in a nationwide registry study.

ESC Professional Premium Access

Lower dose direct oral anticoagulation and warfarin in atrial fibrillation. Ischemic stroke, intracranial hemorrhage and mortality in a nationwide registry study.

Session: Stroke prediction and prevention in atrial fibrillation

Topic: Stroke in Atrial Fibrillation

Speaker: Doctor O. Halminen (Espoo, FI)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Olli Halminen

Aalto University, Espoo (Finland)

0 follower

7 more presentations in this session

Atrial fibrillation burden and timing of anticoagulation therapy in patients with screen-detected and clinically-diagnosed AF

Speaker: Doctor W. Sun (Shatin, HK)

Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients

Speaker: Mr P. Nielsen (Aalborg, DK)

Validation of novel electrocardiographic classification for stroke prediction in patients with atrial fibrillation undergoing cardioversion

Speaker: Doctor A. Relander (Turku, FI)

10-year trends in oral anticoagulation therapies and ischemic stroke among 157,583 patients with non-valvular atrial fibrillation

Speaker: Doctor W. Sun (Shatin, HK)

Left atrial appendage morphology and mitral annular plane systolic excursion predict stroke in patients with atrial fibrillation and high thromboembolic risk.

Speaker: Professor D. Blendea (Cluj Napoca, RO)

Access the full session

Stroke prediction and prevention in atrial fibrillation

Speakers: Doctor O. Halminen, Doctor W. Sun, Mr P. Nielsen, Doctor A. Relander, Doctor W. Sun...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources